Common Cold News and Research

RSS

Mapping peripheral blood glycoprotein profiles of COVID-19 patients

A team of researchers recently analyzed differential protein glyco-isoform distributions of symptomatic and asymptomatic coronavirus disease 2019 patients.

11 Jan 2022

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells.

10 Jan 2022

Children with pre-existing immunity to common cold demonstrate better protection against COVID-19

New data shows that, compared to adults, children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preferentially activate pre-existing acquired immunity to prevalent common cold coronaviruses that cross-react with SARS-CoV-2 and protect them from severe disease.

24 Dec 2021

Investigating potential cross-protection against SARS-CoV-2 after previous exposure to bovine coronavirus

Researchers have conducted an investigation to probe the similarity of viral epitopes between bovine coronavirus (BCoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Dec 2021

Omicron is more transmissible but may have milder symptoms for many people, expert says

If the first reports coming out of South Africa are correct, Omicron might be more transmissible than the current dominant Covid-19 strain, Delta, but cause less severe symptoms for many people. A leading expert says that, if the new strain does turn out to be milder for some people, that creates a new set of problems.

16 Dec 2021

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Researchers observed that symptom presentation of SARS-CoV-2 infections at the community level was very similar to that of endemic human coronavirus infections.

14 Dec 2021

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

In this study cohort, SARS-CoV-2 infections were confirmed via the RT-PCR test.

13 Dec 2021

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

New research suggests that common human coronaviruses, such as those that cause the common cold, could also shed light on the patterns of SARS-CoV-2 reinfection.

13 Dec 2021

UCLA research points the way towards a longer-lasting COVID vaccine

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.

11 Dec 2021

SARS-CoV-2 S2 immunization as a pan-coronavirus vaccine approach

A new mouse model suggests that prior HCoV-OC43 S immunity primes neutralising antibody responses to otherwise subimmunogenic SARS-CoV-2 S exposure as well as promotes S2-targeting antibody responses.

6 Dec 2021

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

As the COVID-19 pandemic nears the two-year mark, Northwestern Medicine scientists continue to tackle every facet of the disease, from investigating coronavirus vaccines' potential for providing immunity against similar coronaviruses to developing novel rapid antigen-based tests and examining disparities in COVID-19 case and mortality rates in Chicago.

30 Nov 2021

COVID-19 became more lethal in the U.K. in late 2020, statistical analysis suggests

A new statistical analysis supports beliefs that COVID-19 became more lethal in the U.K. in late 2020, while also suggesting that multiple factors - not just the alpha variant of the virus that causes COVID-19 - were to blame.

25 Nov 2021

Combination of iota-carrageenan and xylitol as a potential nasal spray for COVID

Researchers determine the inhibition capacity of iota-carrageenan and xylitol in three different candidate preservative-free formulations.

24 Nov 2021

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

A recent study has demonstrated that SARS-CoV-2 infection induces a significantly lower interferon response than rhinovirus infection.

24 Nov 2021

Relaxation of COVID-19 restrictions led to the reemergence of seasonal respiratory viruses in Houston

A Houston Methodist study showed a rapid return of seasonal respiratory viruses after COVID-19 restrictions were relaxed in Texas, demonstrating the effectiveness of masking, distancing and other precautionary measures at stopping the spread of many respiratory illnesses, not just COVID-19.

24 Nov 2021

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

A drug class that blocks the activity of blood platelets and prevents clotting—P2Y12 inhibitors—failed to extend survival or lessen disease severity in patients with COVID-19 who were hospitalized but had a relatively moderate case, a new study finds.

15 Nov 2021

Common Cold News and Research

Mapping peripheral blood glycoprotein profiles of COVID-19 patients

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

Children with pre-existing immunity to common cold demonstrate better protection against COVID-19

Investigating potential cross-protection against SARS-CoV-2 after previous exposure to bovine coronavirus

Omicron is more transmissible but may have milder symptoms for many people, expert says

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

UCLA research points the way towards a longer-lasting COVID vaccine

SARS-CoV-2 S2 immunization as a pan-coronavirus vaccine approach

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

COVID-19 became more lethal in the U.K. in late 2020, statistical analysis suggests

Combination of iota-carrageenan and xylitol as a potential nasal spray for COVID

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

Relaxation of COVID-19 restrictions led to the reemergence of seasonal respiratory viruses in Houston

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

University of Oxford begins Phase I trial to test Ebola vaccine

New discovery could lead to the creation of a pan-coronaviruses vaccine

Coronaviruses synthesize RNA in membrane-bound compartments

COVID-19 drug candidate with wide-ranging antiviral activity

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News